NYC Ambulance Companies Pay $2.85M Related to Unnecessary Trips

Three New York City ambulance companies -- Metropolitan Ambulance & First Aid Corp. (now known as SEZ Metro Corp.), Metro North Ambulance Corp. (now known as SEZ North Corp.), and Big Apple Ambulance Service Inc. (formerly known as United Ambulance) -- have paid the United States $2.85 million to resolve false claims made to Medicare, the Justice Department announced June 4. The United States stipulated to the dismissal of the False Claims Act qui tam suit against the companies, including their president, Steve Zakheim.

The United States alleged that the companies and Zakheim used, or caused the use of, falsified records to appeal a Medicare program refund demand. Medicare had demanded the companies return millions of dollars they had been paid for medically unnecessary ambulance trips. Under Medicare rules, the companies could bill for these expensive non-emergency transports only if the patient could not be transported by any other means, such as by car or by wheelchair van. Medicare audited the companies' past billings and concluded that the companies had charged Medicare tens of millions of dollars for ambulance trips that did not meet this standard. Medicare demanded a refund and afforded the companies an extensive informal and formal appeals process to prove that their billings were proper.

The government contended that, rather than contesting the refund demand fairly, the companies resorted to fraud when they could not otherwise prove an ambulance was medically needed. According to the suit (United States ex rel. Kaplan v. Metropolitan Ambulance & First-Aid Corp. et al., Civil Action No. 00-3010 [E.D.N.Y.]), in their ensuing appeals, the companies used, and Zakheim caused the use of, hundreds of letters attesting to the need for an ambulance that were forged or otherwise purported to come from some neutral, disinterested health care provider when they in fact did not.

"Those who benefit from Medicare must play by the rules," said Tony West, assistant attorney general for DOJ's Civil Divisio. "We will diligently protect taxpayer dollars from those who use fraud and deceit to take advantage of federal health care programs."

U.S. Attorney Loretta E. Lynch added, "Health care providers who seek to defraud the Medicare program by submitting false documents will be vigorously pursued and held accountable for their fraud."

This action was originally filed by Larry Kaplan, a former chief financial officer for one of the companies, under the False Claims Act. The qui tam, or whistleblower, provisions of the act permit private citizens to file suit on behalf of the United States and share in any recovery. Kaplan's share of the settlement announced June 4 will be $618,450.

DOJ noted this settlement is part of the government's emphasis on combating health care fraud. One of the most powerful tools in that effort is the False Claims Act, which DOJ said it has used to recover approximately $3 billion since January 2009 in cases involving fraud against federal health care programs.

Product Showcase

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • EMSL Analytical, Inc. - Air Sampling Supplies & Testing Labs

    EMSL Analytical, Inc. operates laboratories throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in fast laboratory results for Asbestos, Mold, Silica, Lead & Metals, Bacteria, Legionella, USP , Combustion By-Products, VOC’s, Radon, PCB’s, Formaldehyde, METH/Fentanyl, Identification of Dust & Unknowns. Sampling Pumps, Cassettes, Media & Supplies available. Reach us at 1-800.220.3675 Read More

Featured

Webinars